We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

I asked ChatGPT for the best S&P 500 stocks to buy and it recommended…

ChatGPT believes these three S&P 500 stocks are the best investments right now. Motley Fool analyst Zaven Boyrazian takes a closer look.

| More on:
Tariffs and Global Economic Supply Chains

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

The S&P 500‘s home to some of the largest enterprises in America. And over the last five years, simply replicating the performance of this index with a tracker fund would have more than doubled an investor’s money. But for stock pickers, the returns have been even more explosive.

Take Nvidia as an example. By successfully capitalising on the artificial intelligence (AI) spending tailwinds, the GPU chip designer has seen its share price skyrocket by over 1,400% during the same period!

Should you buy Visa shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

This goes to show that by investing in top notch stocks, some tremendous gains can be unlocked. So with that in mind, I asked ChatGPT what it believes are the best S&P 500 shares to buy right now that aren’t in the ‘Magnificent 7’.

A financial kingpin

The first pick was Visa (NYSE:V). Chances are this business needs no introduction. Its technology infrastructure powers an estimated 39% of all debit and credit card electronic payments worldwide. And since the firm charges a small fee on each transaction moving through its payment network, the business is a cash generating machine.

As such, the balance sheet is in tip-top shape. And with more purchasing activity shifting away from traditional cash transactions, the business has ample long-term tailwinds to drive growth moving forward. That certainly sounds like a compelling investment case, so what’s the catch?

Despite its dominant position, Visa isn’t without its risks. Regulators have been clamping down on the firm’s fee structure, limiting the group’s ability to expand profit margins. Its enormous market share also puts it squarely in the eyes of anti-trust investigators to protect customers and consumers. That’s a handicap that many of its fintech rivals don’t have, making life a lot easier for disruptive start-ups in the fintech space.

So is this a good S&P 500 stock to consider buying in May? I think it definitely deserves a closer look. The group’s valuation is pretty demanding, with a price-to-earnings ratio of 52. But given the quality of this business, that’s a premium that might be worth paying.

Opportunities in healthcare

Another two stocks ChatGPT recommended as top-tier companies are Johnson & Johnson and UnitedHealth. Both a prominent players in the healthcare sector. And considering demand for healthcare products and services is unlikely to disappear anytime soon, both businesses appear to have ample longevity.

Those are obviously some attractive traits, particularly for investors looking to load up on defensive stocks. However, just like Visa, these companies have their weak spots.

Developing new drugs and medical devices is a regulatory nightmare that’s enormously expensive and highly competitive. Johnson & Johnson’s size certainly helps in this regard, but clinical trial failures on critical projects can be disastrous, especially if a competing product succeeds.

Meanwhile, health insurance is an enormously complicated business. If the company doesn’t price its plans correctly, losses from customer claims could drive earnings in the wrong direction.

The bottom line

All three S&P 500 stocks appear to show promise. But are they the best S&P 500 stocks investors can buy right now? I’m not convinced. I’m certain there are far more promising opportunities hidden in the US’s flagship index waiting to be discovered.

Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has recommended Nvidia and Visa. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Up nearly 1,400% in 5 years! But are Rolls-Royce shares still secretly undervalued?

After skyrocketing, Rolls-Royce shares are now near an all-time high, but could the engineering giant still have more room to…

Read more »

Happy senior couple hugging and enjoying retirement at home
Investing Articles

By mid-2027, analysts expect £5,000 in Barclays shares to be worth…

Barclays shares have outperformed the FTSE 100 by a wide margin over the last year. And City analysts expect to…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Near 5-year lows, here’s what the experts say about the Diageo share price

Ben McPoland's questioning his sanity after investing in Diageo. Where do institutional analysts see its share price heading over the…

Read more »

British Airways cabin crew with mobile device
Investing Articles

Up 165% but still with a P/E of 7.9. Is the IAG share price a generational bargain?

The IAG share price has been on fire for the last two years, delivering some of the biggest returns in…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Here’s the latest Vodafone share price forecasts for 2027

Up 35% in 12 months, the Vodafone share price is beating the stock market right now, but can this momentum…

Read more »